Pfizer CentreOne - Active Pharmaceutical ingredients (API)
Pfizer CentreOne™ is a global contract manufacturer that focuses on API synthesis and sterile injectables fill-finish.
What is our history?
Our company was born of the September 2015 union of Pfizer CentreSource, a global leader in specialty APIs, and Hospira One 2 One, one of the world’s premier sterile-injectables CMOs. As a combined organization, we’ve brought together the best of our manufacturing capabilities to provide a wider array of services and technologies to our biopharmaceutical partners. Although Pfizer CentreOne is a new name, we’re not new to the industry, with more than 40 years of contract manufacturing experience.
What are our services?
We concentrate on segments and specialties where we excel, while constantly seeking to expand our service offerings and manufacturing footprint to meet your needs. Today, we’re aligned into two primary areas of expertise: API and drug product. Specifically, we focus on:
- Small-molecule steroid and hormone intermediates and APIs
- Custom small-molecule API synthesis, and
- Sterile injectables fill-finish
How are we structured within Pfizer, and how does that benefit you?
Pfizer CentreOne is a self-contained CMO embedded within Pfizer. We have our own dedicated team that reports through Pfizer’s Global Established Pharmaceuticals commercial organization. This means that we make decisions based solely on your needs, while harnessing the quality, capabilities and regulatory strength of Pfizer global manufacturing on your behalf.
Moreover, since our CMO is dedicated to growth, Pfizer has reserved capacity—time, equipment and resources—for Pfizer CentreOne across the facilities that manufacture our partners’ drugs. Now and for the long haul, we’re dedicated to you and your compound. Learn more at www.pfizercentreone.com.
Get full access to our capabilities, click here.